$POCI
PRECISION OPTICS CORPORATION, INC.

2024 Q4 Form 10-Q Financial Statement

#000168316824008113 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $4.527M $4.197M $4.321M
YoY Change -6.16% -2.87% -15.02%
Cost Of Revenue $3.457M $3.080M $2.858M
YoY Change 2.48% 7.77% -14.97%
Gross Profit $1.070M $1.117M $1.464M
YoY Change -26.26% -23.66% -15.14%
Gross Profit Margin 23.64% 26.62% 33.87%
Selling, General & Admin $1.662M $1.964M $1.656M
YoY Change -14.03% 18.57% 10.72%
% of Gross Profit 155.36% 175.74% 113.15%
Research & Development $317.7K $400.7K $212.8K
YoY Change 43.3% 88.32% -13.33%
% of Gross Profit 29.7% 35.86% 14.54%
Depreciation & Amortization $48.29K $51.56K
YoY Change -6.35% -1.62%
% of Gross Profit 4.32% 3.52%
Operating Expenses $1.980M $2.364M $1.869M
YoY Change -8.13% 26.51% 7.33%
Operating Profit -$910.0K -$1.247M -$405.3K
YoY Change 29.23% 207.66% 2343.14%
Interest Expense -$64.31K $59.12K
YoY Change -208.78% 3.86%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.311M -$464.4K
YoY Change 182.34% 563.46%
Income Tax
% Of Pretax Income
Net Earnings -$969.7K -$1.311M -$464.4K
YoY Change 27.79% 182.34% 531.76%
Net Earnings / Revenue -21.42% -31.24% -10.75%
Basic Earnings Per Share -$0.15 -$0.21 -$0.08
Diluted Earnings Per Share -$0.15 -$0.21 -$0.08
COMMON SHARES
Basic Shares Outstanding 6.350M shares 6.350M shares 6.067M shares
Diluted Shares Outstanding 6.350M shares 6.217M shares 6.067M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $635.6K $1.370M
YoY Change -53.62% 104.55%
Cash & Equivalents $212.4K $635.6K $1.370M
Short-Term Investments
Other Short-Term Assets $288.5K $361.8K
YoY Change -20.27% 90.42%
Inventory $3.848M $3.461M $2.971M
Prepaid Expenses $275.0K $288.5K $361.8K
Receivables $3.506M $3.124M $4.533M
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.842M $7.508M $9.237M
YoY Change 0.12% -18.71% 31.36%
LONG-TERM ASSETS
Property, Plant & Equipment $450.3K $469.6K $412.7K
YoY Change -6.49% 13.79% -30.17%
Goodwill $8.824M $8.824M $8.824M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $9.669M $9.730M $9.832M
YoY Change -1.98% -1.03% -3.01%
TOTAL ASSETS
Total Short-Term Assets $7.842M $7.508M $9.237M
Total Long-Term Assets $9.669M $9.730M $9.832M
Total Assets $17.51M $17.24M $19.07M
YoY Change -1.06% -9.6% 11.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.738M $2.143M $1.734M
YoY Change 63.4% 23.63% -24.82%
Accrued Expenses $1.261M $1.411M
YoY Change -10.59% 10.22%
Deferred Revenue $1.418M $1.107M $1.425M
YoY Change 22.42% -22.35% 37.96%
Short-Term Debt $500.0K $0.00
YoY Change
Long-Term Debt Due $427.8K $285.9K $513.3K
YoY Change -16.66% -44.3% 38.18%
Total Short-Term Liabilities $6.413M $5.336M $5.127M
YoY Change 48.7% 4.09% -1.34%
LONG-TERM LIABILITIES
Long-Term Debt $1.612M $1.747M $2.048M
YoY Change -16.02% -14.69% 9.77%
Other Long-Term Liabilities $0.00 $146.0K
YoY Change -100.0% -85.82%
Total Long-Term Liabilities $1.612M $1.747M $2.048M
YoY Change -16.02% -14.69% 9.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.413M $5.336M $5.127M
Total Long-Term Liabilities $1.612M $1.747M $2.048M
Total Liabilities $8.035M $7.101M $7.174M
YoY Change 28.92% -1.02% 1.6%
SHAREHOLDERS EQUITY
Retained Earnings -$53.47M -$52.50M -$48.70M
YoY Change 8.11% 7.8% 1.11%
Common Stock $63.56K $63.50K $60.67K
YoY Change 4.75% 4.68% -64.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.476M $10.14M $11.69M
YoY Change
Total Liabilities & Shareholders Equity $17.51M $17.24M $19.07M
YoY Change -1.06% -9.6% 11.07%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$969.7K -$1.311M -$464.4K
YoY Change 27.79% 182.34% 531.76%
Depreciation, Depletion And Amortization $48.29K $51.56K
YoY Change -6.35% -1.62%
Cash From Operating Activities -$318.6K -$1.373M
YoY Change -76.79% -787.41%
INVESTING ACTIVITIES
Capital Expenditures $24.35K $30.77K
YoY Change -20.87% 92.08%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$28.10K -$43.52K
YoY Change -35.43% 49.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $128.3K $128.3K
YoY Change 0.0% 38.19%
Cash From Financing Activities $577.0K -$138.9K
YoY Change -515.49% 35.08%
NET CHANGE
Cash From Operating Activities -$318.6K -$1.373M
Cash From Investing Activities -$28.10K -$43.52K
Cash From Financing Activities $577.0K -$138.9K
Net Change In Cash $230.3K -$1.555M
YoY Change -114.81% -2395.67%
FREE CASH FLOW
Cash From Operating Activities -$318.6K -$1.373M
Capital Expenditures $24.35K $30.77K
Free Cash Flow -$343.0K -$1.404M
YoY Change -75.57% -864.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
3079723 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
2857644 usd
CY2024Q3 dei Security12g Title
Security12gTitle
Common Stock, $0.01 par value
CY2024Q3 us-gaap Gross Profit
GrossProfit
1117330 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1463611 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
400659 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
212758 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1963612 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1656146 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2364271 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1868904 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1246941 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-405293 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
64306 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
59122 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1311247 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-464415 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6216630 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6216630 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6066518 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6066518 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
10067788 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1204542 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
149364 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1311247 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
10137447 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
12046592 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
108746 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-464415 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
11690923 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1311247 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-464415 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48290 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
51564 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
149364 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
108746 usd
CY2024Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4376 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4376 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-421896 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
625719 usd
CY2024Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
592521 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
194995 usd
CY2024Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10889 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
112120 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
746038 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-698603 usd
CY2024Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-65804 usd
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
250293 usd
CY2024Q3 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
270097 usd
CY2023Q3 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
307884 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-318622 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1372989 usd
CY2024Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24349 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30770 usd
CY2024Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3750 usd
CY2023Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12747 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28099 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-43517 usd
CY2024Q3 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
11212 usd
CY2023Q3 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
10562 usd
CY2024Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
128315 usd
CY2023Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
128315 usd
CY2024Q3 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
15000 usd
CY2023Q3 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
-0 usd
CY2024Q3 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
500000 usd
CY2023Q3 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
-0 usd
CY2024Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1204542 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2024Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
27000 usd
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
577015 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-138876 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
230294 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1555383 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
405278 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2925852 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
635572 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1370469 usd
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zSGGgC9m1vl5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline"><span id="xdx_86B_z3uM2XRLvSX">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1329236 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1123140 shares
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1311247 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1311247 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-464415 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-464415 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6216630 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6216630 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6066518 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6066518 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2024Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2024Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
1965096 usd
CY2024Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
1570135 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
153223 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
157406 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1342302 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1140559 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
3460621 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
2868100 usd
CY2024Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
1516667 usd
CY2024Q3 us-gaap Loans Payable
LoansPayable
562500 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
285901 usd
CY2024Q3 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
18736 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
46502 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1746764 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
148644 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
594578 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
594578 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
594578 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
146789 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
2079167 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
146247 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
146247 usd
CY2024Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-3 reverse stock split
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
149364 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
108746 usd
CY2024Q3 us-gaap Revenues
Revenues
4197053 usd
CY2023Q3 us-gaap Revenues
Revenues
4321255 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1172350 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1174690 usd
CY2024Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
471617 usd
CY2023Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
433119 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-537421 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-182826 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1106546 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1424983 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-008113-index-headers.html Edgar Link pending
0001683168-24-008113-index.html Edgar Link pending
0001683168-24-008113.txt Edgar Link pending
0001683168-24-008113-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
poci-20240930.xsd Edgar Link pending
poci_ex3101.htm Edgar Link pending
poci_ex3102.htm Edgar Link pending
poci_ex3202.htm Edgar Link pending
poci_i10q-093024.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
poci-20240930_cal.xml Edgar Link unprocessable
poci-20240930_def.xml Edgar Link unprocessable
poci-20240930_lab.xml Edgar Link unprocessable
poci-20240930_pre.xml Edgar Link unprocessable
poci_i10q-093024_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending